NPS Pharmaceuticals Inc. (NPSP) announced Tuesday that it has re-gained the full worldwide rights to teduglutide and recombinant human parathyroid hormone 1-84 from Takeda Pharmaceutical.
NPS Pharmaceuticals gapped open higher Tuesday and is now up 1.63 at $10.67 on above average volume. The stock is now challenging the highs of the year, trading at a 5-month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.